President Recep Tayyip Erdoğan on Wednesday announced the emergency use approval of Turkey’s first domestically-developed coronavirus vaccine, Agence France-Presse reported.
Turkovac in June entered Phase III trials involving 40,800 participants in Turkey. No official data about its efficacy have been released.
But the health ministry’s coronavirus advisory board member Ateş Kara told Turkish media that it was “very successful” and could be “a little better in comparison with other inactivated vaccines”.
“No individuals vaccinated with Turkovac have had a severe form of Covid-19 requiring hospitalization or intensive care so far,” Kara was quoted as saying last weekend.
Developers said the Turkovac vaccine works along the same scientific principles as China’s Coronavac, which Turkey has been using since the start of the year.
Turkey has administered at least two shots to 85.6 percent of its adult population, officially recording 80,000 Covid-19 deaths.
Hosting a major summit of African leaders, Erdoğan last weekend pledged to send 15 million vaccine doses to countries in the world’s poorest continent, calling the low vaccination rates there were a blot on humanity.